Clinical trial Recruiting at 1 site Interventional Ages 18 and up

SPARK-CGM: Boosting CGM Use in Primary Care

Official title: Supporting Primary Care Adoption, Resources, and Knowledge for Continuous Glucose Monitoring

Run by Montefiore Medical Center · NCT07548372 · Data updated 2026-11-12

This program tests whether a multi-component package can help primary care clinics prescribe continuous glucose monitoring more often for adults with diabetes on insulin.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20000 (estimated)
SponsorMontefiore Medical Center
Academic / other
Locations1 site (The Bronx, New York)
StatusRecruiting
StartedMay 1, 2026
Main results expectedMay 2028
Study endsMay 2028
Registry record updatedJune 23, 2026
Trial IDNCT07548372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with diabetes treated with insulin receiving care at participating Montefiore primary care sites, and staff involved in CGM prescribing and education.

Probably not a fit

Patients not eligible for CGM (e.g., not on insulin or not seen at participating sites) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SPARK-CGM is a hybrid effectiveness-implementation project that provides education, streamlined prescribing, insurance workflows, and staff training to increase new CGM prescriptions in adult diabetes patients treated with insulin at Montefiore primary care sites. The study uses a stepped-wedge cluster randomized design, where clinics gradually transition from usual care to the SPARK-CGM approach over time. The goal is to see if the intervention improves CGM uptake, reduces administrative barriers, and supports better glycemic management in real-world primary care settings. Outcomes include prescribing rates and integration of CGM workflows across clinics and providers.

Why it matters

Potential benefit: If successful, patients could access CGM more readily, potentially improving blood sugar control and quality of life.

How similar studies have gone: Previous efforts to implement CGM in primary care have shown promise when workflow and education barriers are addressed, though this exact multi-component, stepped-wedge approach is developing the evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Clinic level:

* All adult Montefiore primary care sites
* Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff

Patient level:

* Age 18 years or older
* Receive primary care at participating sites
* Diagnosis of any diabetes mellitus
* Treated with insulin therapy

Exclusion Criteria:

Clinic level:

\- Sites participating in pilot phase of CGM initiative

Patient level:

\- Existing CGM prescription within 24 months before the study start

Where it's running

  • Montefiore Medical Group (MMG)
    The Bronx, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.